TherapeuticsMD (TXMD) Gross Margin (2010 - 2023)
TherapeuticsMD (TXMD) reported Gross Margin of 100.00% for Q4 2023, unchanged from 100.00% a year earlier and up 200.00 percentage points from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Gross Margin (2010 - 2023) Analysis & Trends
Dating back to Q1 2011, TherapeuticsMD's Gross Margin record includes 50 quarters.
- Gross Margin has a five-year change of +17.00 percentage points (FY2018 to FY2023).
- By year, Gross Margin came in at 98.00% in FY2022 (+52.49 pp), 45.51% in FY2021 (-29.86 pp), 75.37% in FY2020 (-11.87 pp) and 87.24% in FY2019 (+4.24 pp).
- Five-year quarterly Gross Margin spans a low of -100.00% in Q3 2023 and a high of 2082.45% in Q1 2022.
- Year over year, Gross Margin gained in two of the last four quarters, with an average year-over-year change of +12.24 percentage points.
- The high point for year-over-year Gross Margin in five years was Q1 2022 (a gain of 2006.04 percentage points); the low point was Q1 2023 (a drop of 1982.45 percentage points).
- Per Business Quant data, the three quarters before Q4 2023 came in at -100.00% (Q3 2023), 100.00% (Q2 2023) and 100.00% (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 75.71% |
| 10 | TherapeuticsMD | 20.14 Mn | -12.07 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 100.00% |
| Sep 30, 2023 | -100.00% |
| Jun 30, 2023 | 100.00% |
| Mar 31, 2023 | 100.00% |
| Dec 31, 2022 | 100.00% |
| Mar 31, 2022 | 2,082.45% |
| Dec 31, 2021 | 74.64% |
| Sep 30, 2021 | 79.21% |
| Jun 30, 2021 | 82.04% |
| Mar 31, 2021 | 76.41% |
| Dec 31, 2020 | 75.28% |
| Sep 30, 2020 | 83.05% |
| Jun 30, 2020 | 58.88% |
| Mar 31, 2020 | 77.84% |
| Dec 31, 2019 | 81.90% |
| Sep 30, 2019 | 93.91% |
| Jun 30, 2019 | 79.45% |
| Mar 31, 2019 | 80.67% |
| Dec 31, 2018 | 81.33% |
| Sep 30, 2018 | 79.88% |
API Access
TherapeuticsMD Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();